Cates, CJ
(2011)
Safety of tiotropium: Indirect evidence suggests the Respimat inhaler is riskier than the Handihaler.
BRITISH MEDICAL JOURNAL, 342.
pp. 1-2.
ISSN 0959-8138
https://doi.org/10.1136/bmj.d2970
SGUL Authors: Cates, Christopher Joseph
Preview |
|
["document_typename_application/pdf; charset=binary" not defined]
Published Version
Available under License St George's repository terms & conditions.
Download (743kB)
| Preview
|
Item Type: |
Article
|
Additional Information: |
PubMed ID: 21672998 |
Keywords: |
Bronchodilator Agents, Humans, Pulmonary Disease, Chronic Obstructive, Randomized Controlled Trials as Topic, Scopolamine Derivatives, Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine |
SGUL Research Institute / Research Centre: |
Academic Structure > Population Health Research Institute (INPH) |
Journal or Publication Title: |
BRITISH MEDICAL JOURNAL |
ISSN: |
0959-8138 |
Related URLs: |
|
Dates: |
Date | Event |
---|
14 June 2011 | Published |
|
Web of Science ID: |
WOS:000291932100001 |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/2681 |
Publisher's version: |
https://doi.org/10.1136/bmj.d2970 |
Statistics
Item downloaded times since 06 Dec 2012.
Actions (login required)
|
Edit Item |